Turn this list into pipeline.
Startup Companies in Cambridge: 69 Active Firms (2026)
Startup companies in Cambridge build early-stage products and services with scalable business models across the city’s technology cluster.
Buying centres tend to sit around commercialising research, specialist software, scientific services, data tools and service-led technology for corporate customers. The customer base is mostly business-to-business, with sales into smaller firms, mid-market buyers and technical teams inside larger organisations rather than broad consumer markets. Engagements are often paid pilots, proof-of-concept licences, technical service contracts or narrow departmental subscriptions; founder-led sales and short reference cycles matter more than procurement theatre at this stage. The common thread is early commercial validation, not a single sector vertical.
Read more
Cambridge has 69 active trading startup-tagged companies in this list, a compact cohort by UK standards but one with a visible employment footprint: reported headcount totals 945 people. The composition still skews early stage: 15 were incorporated since 2022, while only 1 reports turnover above £5M, so the revenue distribution appears concentrated below later-stage scale-up levels. For researchers, that makes the city more useful as a funnel of commercially active early ventures than as a broad sample of mature high-turnover businesses.
Startup status does not create a separate UK permissions regime. The common baseline is company-law administration: confirmation statements, accounts and identity checks before some filings. Activity then determines the specialist overlay. Cambridge startups offering regulated financial services need FCA permission; those touching energy supply, aviation, healthcare data or medical products may meet OFGEM, CAA, ICO or MHRA requirements. The same firm can move from low-friction software sales to regulated operations if it begins holding client money, processing sensitive personal information or making clinical claims, so lifecycle labelling is a poor substitute for activity-based review.
Commercial progression appears uneven rather than linear. Many Cambridge startups tend to begin with grant-funded research, founder networks or a small set of early customers, then face a harder step when procurement, compliance evidence and repeatable sales processes become unavoidable. The scarcity of high-turnover firms suggests that the funnel narrows before maturity, which is common in deep-technology and specialist scientific markets. Consolidation may come through hiring, licences and asset purchases as much as formal acquisitions. The better-positioned cohorts are likely to be those that can turn technical credibility into repeatable contracts without adding regulatory burden faster than revenue.
69
Active firms
2026
15
Incorporated since 2022
Cambridge cohort
1
Above £5M turnover
Cambridge cohort
Key facts
About 1% of the trading cohort reports turnover above £5M (1 of 69 firms) — the rest sits below that revenue band.
21% of the cohort was incorporated since 2022 (15 firms), so a sizeable share is in its first few filing cycles.
Startup is a lifecycle and size tag rather than a separate UK regulatory category, so ordinary company-law obligations still apply.
Sector-specific permissions still apply where the activity falls under financial services, energy supply, aviation, healthcare or legal regulation, including the FCA, OFGEM, CAA or MHRA.
DBT estimated 5.5 million private-sector businesses at the start of 2024, with SMEs accounting for 99.8% of the business population.
ONS reported 2.725 million UK businesses registered for VAT and/or PAYE as of March 2024, down 0.1% from March 2023.
A 2024 global startup ecosystem report ranked Silicon Valley #1 globally, with New York City and London tied at #2.
Top Cambridge startup companies
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops wireless sensors and analytics software for remote condition monitoring of rotating industrial equipment. Collects operational data and provides alerts and diagnostics via web, mobile and…
Serves B2B asset owners and operators in water/wastewater, utilities, manufacturing, and oil and gas, especially organisations managing rotating industrial equipment in remote or hard-to-reach sites.
Financial Health
DistressedDistressed · -10% CAGR over 4y
Location
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsDevelops IoT-based insect monitoring systems that detect and track pest activity and send real-time alerts. Provides sensor pods and a data platform used for bed bug detection, forestry pests such as…
Serves B2B organisations affected by insect pests, including forestry operators, date palm plantation managers and hospitality/accommodation providers needing bed bug monitoring, plus partners…
Financial Health
StrongStrong · Growing, Hiring · 36% CAGR over 5y
Location
Pivotal Future Ltd
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsProvides biodiversity and nature‑risk data collection and analytics through an AI-powered platform. Enables organisations to monitor species and ecosystems across sites and supply chains, manage…
Serves businesses and investors managing nature-related risks across sites, landscapes and supply chains, including organisations needing biodiversity data for sourcing, investment, operations and…
Financial Health
HealthyHealthy · Hiring · 122% CAGR over 3y
Location
Signaloid Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops computing platforms and hardware for executing probabilistic and stochastic workloads. Provides cloud and on‑premise tools that process probability distributions to accelerate simulations,…
Serves B2B technical teams in quantitative finance, digital banking, AI/ML, robotics, automotive, industrial automation, engineering design and supply chain planning with stochastic or…
Financial Health
StrongStrong · Growing, Hiring · 57% CAGR over 4y
Location
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsProvides AI-powered imaging and data analysis services for clinical trials, including image management, biomarker development, and analysis of radiology and healthcare datasets to support drug…
Serves biopharma and pharmaceutical clinical trial sponsors developing lung and heart disease therapies, especially teams running trials in IPF, pulmonary fibrosis, pulmonary hypertension and…
Financial Health
StrongStrong · Hiring · 20% CAGR over 2y
Location
Trajectory
2y · 2023–NowDevelops laboratory technology for single‑cell functional analysis. Its Envisia platform uses droplet-based assays to study cell interactions, biomolecule secretion and targeted cell killing,…
Serves life sciences researchers and R&D teams in biotech, pharmaceutical, diagnostic and academic research organisations working in basic/translational research, drug discovery and therapeutic…
Financial Health
Insufficient historyInsufficient history
Location
Plastometrex
Trajectory
5y · 2022–NowFinancial sub-scores
Computed from 5 filingsDevelops and manufactures mechanical testing instruments using profilometry‑based indentation plastometry to measure stress–strain curves and strength properties of metals from indentation data, with…
Serves materials scientists, engineers and testing teams in manufacturing, additive manufacturing, aerospace/defence, inspection and certification, research institutions and universities working with…
Financial Health
StrongStrong · Hiring · 32% CAGR over 4y
Location
BLECON LIMITED
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops Bluetooth beacon networking technology for real‑world asset tracking and data collection. Provides smart beacons, hotspot gateways, network infrastructure, and a cloud platform with APIs for…
Serves B2B operations, IT and product teams needing asset visibility, including industrial operators, logistics/workflow teams, beacon and gateway vendors, and cloud application developers.
Financial Health
StrongStrong · Hiring · 41% CAGR over 2y
Location
FULL MATRIX LTD
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops and manufactures ultrasonic sensing systems and EMAT transducers for remote inspection and condition monitoring of infrastructure. Provides simulation and modelling, laser vibrometry…
Serves B2B customers in fusion, rail and critical infrastructure sectors, including engineering, R&D and asset integrity teams needing remote inspection and condition monitoring in extreme or…
Financial Health
StrongStrong
Location
CUSP AI LIMITED
Trajectory
1y · 2025–NowDevelops AI models and software to discover and design new chemical materials and molecules. Uses machine learning and computational chemistry to accelerate materials research and identify compounds…
Financial Health
Insufficient historyInsufficient history
Location
LUCIDA MEDICAL LTD
Trajectory
5y · 2022–NowFinancial sub-scores
Computed from 5 filingsDevelops artificial intelligence software that analyses prostate MRI scans to assist clinicians in detecting and diagnosing prostate cancer. The Pi system evaluates imaging data to identify…
Serves healthcare providers, including NHS trusts, hospitals, radiology departments, urology teams and clinicians involved in prostate cancer diagnostic pathways.
Financial Health
StableStable · Hiring · 13% CAGR over 3y
Location
Trimtech Therapeutics Limited
Trajectory
1y · 2025–NowDevelops protein-degrading therapeutics targeting disease-causing protein aggregates. Uses TRIM21-based technologies, including TRIMTAC and TRIMGLUE platforms, to design treatments for central…
Serves the healthcare market for CNS and inflammatory disorders, particularly patients with protein aggregation diseases and the clinicians or healthcare systems treating them.
Financial Health
Insufficient historyInsufficient history
Location
Trajectory
2y · 2024–NowFinancial sub-scores
Computed from 2 filingsDevelops chemical odour and VOC capture technology based on cucurbituril molecules. Supplies AqFresh additives used in nonwovens, textiles, plastics, coatings and liquids to remove odours and…
Sells to B2B manufacturers and product developers in home and pet care, deodorants, absorbent hygiene, automotive interiors, fibres, nonwovens, textiles, coatings, paints and plastics seeking odour…
Financial Health
WeakWeak · -7% CAGR over 1y
Location
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops software that analyses product supply chains and manufacturing data to calculate carbon emissions and efficiency, using engineering models to identify changes that reduce emissions, improve…
Serves B2B companies with complex product value chains, especially manufacturers and product businesses seeking supply chain decarbonisation, product-level emissions insight, and efficiency…
Financial Health
StableStable
Location
Coherence Neuro Ltd
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops bioelectronic medical technology for cancer management, including an implantable brain–computer interface that monitors neural signals and delivers targeted stimulation. The platform…
Serves people with cancer, prospective clinical trial participants and their oncology care teams; also addresses researchers and partners in neurotechnology, neurobiology and cancer therapy.
Financial Health
StrongStrong · Hiring · 183% CAGR over 2y
Location
Genestack
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops data management and integration software for life science research. Provides platforms to catalogue, curate and search multi‑omics and imaging datasets, integrate with existing IT systems,…
Serves R&D, informatics and data teams at pharma, agriscience and consumer goods organizations, as well as life science researchers working with multi-omics, imaging and biological datasets.
Financial Health
DistressedDistressed · -22% CAGR over 4y
Location
Ignota Labs Limited
Trajectory
3y · 2022–NowFinancial sub-scores
Computed from 3 filingsDevelops AI-based bioinformatics and cheminformatics software for in‑silico toxicity prediction in drug development. Analyses clinical and preclinical data to identify causes of drug safety failures…
Sells to pharmaceutical and biotech companies seeking to revive failed or abandoned drug candidates, particularly teams responsible for preclinical to Phase 2 safety, toxicity assessment, and…
Financial Health
WeakWeak
Location
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops liquid biopsy technology for cancer research, including the VTX-1 system that isolates and collects circulating tumour cells from blood samples. Provides tools and services that enable…
Serves cancer researchers, oncology laboratories, academic medical centres, biotech and pharmaceutical teams working on liquid biopsy, precision oncology and anti-metastatic therapy development.
Financial Health
WeakWeak
Location
Develops targeted cancer immunotherapies, including a universal CAR T platform (BRiDGECAR) that combines nfP2X7‑targeted CAR T cells with antibodies. Conducts research and development of treatments…
Targets oncology healthcare markets, ultimately serving cancer patients with liquid and solid tumours worldwide. The site also addresses life sciences investors and eligible existing shareholders.
Location
OXCITAS LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops computational platforms using machine learning, artificial intelligence and systems biology to analyse ageing mechanisms and support discovery of therapeutic interventions. Provides…
Serves businesses in life sciences, particularly pharmaceutical and biotech organisations seeking ageing-related drug discovery and development partnerships, with tailored platform offerings for…
Financial Health
StableStable · -16% CAGR over 4y
Location
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsDevelops biotechnology for cellular rejuvenation. Uses machine learning, single‑cell sequencing and ageing‑clock models to identify gene targets and develop therapeutic candidates aimed at reversing…
Targets healthcare and life-sciences markets focused on age-driven diseases, with initial therapeutic indications including age-related hearing loss, liver fibrosis and systemic sclerosis.
Financial Health
StrongStrong · Hiring · 43% CAGR over 5y
Location
Addresscloud Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsProvides geospatial data and software APIs for insurers to assess geographic and property risk. Platform offers address validation, geocoding, property data, peril and climate risk scores, and…
Serves B2B insurance organisations, including insurers, underwriting teams, insurance brands, coverholders and price comparison websites, with customers referenced worldwide.
Financial Health
StrongStrong · Profitable, Growing, Hiring · 35% CAGR over 4y
Location
TRIPISM LIMITED
Trajectory
4y · 2023–NowFinancial sub-scores
Computed from 4 filingsProvides a software platform for corporate travel programmes, enabling travel teams to manage a travel intranet, communicate policies and supplier benefits, share hotel directories, collect traveller…
Sells to corporate travel teams and travel managers at large and global businesses, including technology, financial services and pharmaceutical companies, with employees who travel for work.
Financial Health
StrongStrong · Hiring · 21% CAGR over 3y
Location
Omnigen Biodata Ltd
Trajectory
4y · 2023–NowFinancial sub-scores
Computed from 4 filingsDevelops biodata platforms and population health registries used for medical research, real‑world analytics, observational studies, and clinical trials, supporting analysis of individual and…
Serves health researchers, life sciences organisations, and healthcare or public health bodies conducting population health research, real-world analytics, observational studies and clinical trials.
Financial Health
StrongStrong · Growing, Hiring · 10% CAGR over 3y
Location
AVATRIAL LIMITED
Trajectory
5y · 2022–NowFinancial sub-scores
Computed from 5 filingsDevelops platforms for cancer drug discovery using patient tissue samples, multi‑omics data generation, and machine learning analysis. Conducts experimental validation of therapeutic targets and…
Serves B2B partners in oncology drug discovery, including healthcare organisations, technology providers and research collaborators focused on personalised cancer treatment development.
Financial Health
WeakWeak
Location
KUBOS SEMICONDUCTORS LTD
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsDevelops semiconductor materials and growth processes for light‑emitting devices. Its cubic gallium nitride (GaN) technology enables production of efficient green, amber and red LEDs and microLEDs…
Serves B2B customers in LED and microLED manufacturing, including display makers for AR/VR and TVs, general lighting producers, and visible light communications developers in fibre optics and LiFi.
Financial Health
StrongStrong · Hiring · 17% CAGR over 3y
Location
Alchera Data Technologies Ltd
Trajectory
4y · 2023–NowFinancial sub-scores
Computed from 4 filingsDevelops software platforms and data analytics tools for transport and mobility networks. Provides data hubs, AI analytics and reporting tools that process real‑time and historical traffic, bus and…
Serves public and private sector transport organisations, including local and transport authorities, bus network planners, public transport officers, highways operators, highways contractors and…
Financial Health
WeakWeak · Hiring · 10% CAGR over 3y
Location
EVER RESOURCE LTD
Trajectory
4y · 2021–NowFinancial sub-scores
Computed from 4 filingsDevelops circular economy technologies that convert waste streams into new materials and industrial products. Focuses on upcycling processes for metals and batteries, carbon and fuels, and chemical…
Serves B2B industrial customers involved in the energy transition, particularly organisations in metals and batteries, carbon and fuels, and industrial chemicals seeking circular, low-carbon supply…
Financial Health
WeakWeak · -8% CAGR over 4y
Location
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops biotechnology-based cement alternatives for the construction industry. Uses bacteria-driven processes to grow limestone crystals and produce biological cement that replaces Portland cement,…
Serves B2B customers in concrete manufacturing, construction materials and low-carbon building supply chains, particularly organisations seeking sustainable alternatives to Portland cement for…
Financial Health
StrongStrong · Growing, Hiring · 50% CAGR over 2y
Location
HYBRIDAERO LIMITED
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops aircraft design concepts and engineering approaches for future aviation. Activities focus on research and development of new aircraft configurations and related aerospace technologies.
Financial Health
StrongStrong · Hiring · 164% CAGR over 2y
Location
Molyon Limited
Trajectory
1y · 2025–NowDevelops lithium-sulfur battery technology and related energy storage systems, focusing on next‑generation rechargeable batteries for electric mobility and other high‑energy‑density power…
Financial Health
Insufficient historyInsufficient history
Location
MATERIALS NEXUS LIMITED
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsDevelops AI-driven materials science technology to discover and design new materials. Uses computational models and data to identify material compositions and properties for applications such as…
Serves B2B customers in critical industries that depend on advanced materials, including energy generation, next-generation transport and infrastructure.
Financial Health
StrongStrong · Hiring · 78% CAGR over 3y
Location
Trajectory
2y · 2024–NowFinancial sub-scores
Computed from 2 filingsDevelops therapeutic antibodies for cardiovascular disease. Lead candidate ISM‑001 inhibits the VEGF‑A165b isoform to promote blood vessel growth, aiming to treat conditions including chronic stable…
Targets the cardiovascular healthcare market, ultimately serving patients with chronic stable angina and peripheral arterial disease, alongside clinicians and healthcare providers treating…
Financial Health
StrongStrong · Hiring · 80% CAGR over 1y
Location
Trajectory
5y · 2022–NowFinancial sub-scores
Computed from 5 filingsDevelops microfabricated microcarrier technology for biological assays, including barcoded SemaCyte micro‑wells that carry adherent cell colonies. Products enable multiplexed cell screening and…
Sells to B2B life sciences customers, particularly pharma, biotech, and research teams running automated adherent-cell assays, high-content screening, and in vitro drug discovery workflows.
Financial Health
StableStable · Hiring · 41% CAGR over 4y
Location
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsDevelops AI software that analyses H&E‑stained tissue images to infer molecular and multi‑omics biomarker profiles. The technology provides rapid tissue analysis for hospitals, laboratories, and…
Sells to hospitals, pathology labs and research organisations needing tissue-based molecular profiling, and serves drug development teams in biotech and pharma. Targets clinical diagnostics and…
Financial Health
WeakWeak · Hiring · 3% CAGR over 4y
Location
KRAI LIMITED
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDesigns computer systems optimized for artificial intelligence applications. Develops hardware and system architectures aimed at improving efficiency and performance of AI workloads, and provides…
Serves B2B organisations developing or deploying AI applications, including technology teams and industry users needing specialised AI computing infrastructure.
Financial Health
StableStable · Hiring · 12% CAGR over 2y
Location
Conundrum Industrial Limited
Trajectory
4y · 2020–NowFinancial sub-scores
Computed from 4 filingsDevelops AI-driven advanced process control software for industrial plants. The platform uses machine learning and physics-based models to monitor data, optimise plant-wide processes, and provide…
Serves metals and mining companies operating industrial plants, targeting process control, operations and digital transformation teams responsible for plant optimisation, throughput, energy use and…
Financial Health
WeakWeak
Location
Mimicrete Ltd
Trajectory
3y · 2022–NowFinancial sub-scores
Computed from 3 filingsDevelops biomimetic self-healing concrete systems for construction and infrastructure. The material uses embedded vascular networks containing healing agents that seal cracks automatically, extending…
Serves construction and infrastructure organisations that specify, build, own or maintain concrete structures, including contractors, developers, engineers and asset owners.
Financial Health
StrongStrong · -20% CAGR over 1y
Location
Exhalation Technology
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops breath‑analysis diagnostic technology for early detection of lung cancer. Its Inflammacheck device analyses biomarkers and breathing patterns in exhaled breath using sensors and AI to…
Sells to healthcare providers and health systems involved in lung cancer screening, including GP and outreach settings. Serves point-of-care and public health buyers seeking accessible screening for…
Financial Health
HealthyHealthy · Hiring · 10% CAGR over 2y
Location
Deepform Limited
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops metal forming technology for sheet metal pressing. Provides patented fold‑shear tooling and processes that integrate into existing manufacturing lines to reduce trim waste and material use…
Serves B2B manufacturers using sheet metal pressing, including automotive OEMs, heavy goods vehicle makers, stampers, beverage can and metal packaging manufacturers, toolmakers, and producers of…
Financial Health
HealthyHealthy · Hiring · 53% CAGR over 2y
Location
TIDALSENSE LIMITED
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops respiratory diagnostic and monitoring technology using AI and breath analysis. Its N‑Tidal platform combines sensors, connected devices and cloud software to detect and monitor conditions…
Serves healthcare providers and payers, NHS respiratory care pathways, clinicians working with COPD and asthma patients, pharmaceutical companies, and patients with respiratory conditions.
Financial Health
StableStable · Hiring · 20% CAGR over 2y
Location
LOTTIELAB LTD
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsProvides a web-based design tool for creating, editing and exporting Lottie animations. Enables teams to import assets from tools like Figma or After Effects, collaborate on motion design, and…
Serves product teams, UI/UX designers, motion designers and freelancers through to enterprise design teams creating animations for websites, iOS, Android and web products.
Financial Health
StableStable · Hiring · 36% CAGR over 3y
Location
Regulatory Genome Development Ltd
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsProvides structured, machine-readable regulatory data and datasets for compliance and governance systems. Aggregates and converts regulatory texts into source-linked data, obligation libraries and…
Sells to RegTech providers, risk and controls software vendors, regulatory authorities and policy teams using compliance, GRC, supervisory and policy analysis systems.
Financial Health
WeakWeak
Location
Camnord Pharma Limited
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsDevelops complex generic pharmaceutical therapies aimed at addressing unmet clinical needs. Focuses on research and development of generic drug formulations and treatments through a Danish‑UK…
Financial Health
StableStable · -21% CAGR over 3y
Location
HUTANBIO LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops microalgae-based biofuel using automated photobioreactors that grow algae with seawater and sunlight. Produces bio‑oil designed as a drop‑in substitute for fossil diesel to decarbonise…
Sells to businesses and fuel supply-chain operators in hard-to-electrify transport sectors, including fleet, logistics, aviation and heavy transport organisations seeking drop-in low-carbon fuel…
Financial Health
HealthyHealthy · Hiring · 46% CAGR over 4y
Location
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops biologic treatments for chronic wounds. Lead product Aurase Wound Gel is an investigational enzymatic therapy designed to debride wound tissue and stimulate repair pathways, and is…
Targets healthcare systems, wound care clinicians and patients with chronic, non-healing wounds, including those considering investigational or expanded-access treatment pathways.
Financial Health
WeakWeak · -2% CAGR over 4y
Location
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsDevelops a no‑code barcode tracking platform with mobile apps for iOS and Android. Enables organisations to create, print, and scan barcodes, manage asset and inventory data, track item history, and…
Serves businesses and organisations needing barcode-based tracking, including warehouses, retailers, manufacturers, facilities teams, IT, automotive, education, logistics, medical, events and…
Financial Health
StrongStrong · Hiring · 60% CAGR over 4y
Location
Tokenovate Limited
Trajectory
4y · 2023–NowFinancial sub-scores
Computed from 4 filingsDevelops software for financial institutions that automates post‑trade processes, including trade lifecycle management, collateral management and repurchase agreement workflows. Uses smart contracts…
Sells to B2B financial institutions in capital markets, including firms managing post-trade operations, collateral, settlement and repo workflows. Targets teams handling trade lifecycle, custodians,…
Financial Health
StableStable · Hiring · 88% CAGR over 3y
Location
Tenyks Limited
Trajectory
5y · 2022–NowFinancial sub-scores
Computed from 5 filingsDevelops a computer vision platform that analyses video from existing security cameras to monitor operations in restaurants and hospitality venues, providing metrics on queue lengths, service times,…
Serves B2B restaurant and hospitality operators, including quick-service and full-service restaurants, drive-thrus, franchises, coffee shops, bakeries, bars and breweries; buyers include operations…
Financial Health
WeakWeak · Hiring · 23% CAGR over 3y
Location
SEARO LABS LTD
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops seaweed-based polymer materials for packaging, including biodegradable flexible films designed to replace single-use plastics. Produces natural, home-compostable materials derived from…
Sells to B2B packaging producers and consumer-goods brands seeking alternatives to single-use plastic, particularly buyers of flexible film and commercial packaging materials.
Financial Health
DistressedDistressed · -81% CAGR over 2y
Location
Unlock all 69 leads
Showing 50 of 69 — +19 more with verified decision-maker contacts, live data, and CRM sync.
How Cambridge startup companies work and how to sell to them
What they do
Cambridge startups usually earn through a mix of early customer revenue, funded development work and repeatable product sales once a technical proposition has been proven. Software-led firms tend to move from free trials or paid pilots into subscription licences, usage-based fees or annual departmental contracts. Scientific and service-led technology firms often sell feasibility work, testing, analysis, prototype development or IP-backed licences before revenue becomes repeatable. Pricing is commonly shaped by scarce founder time, specialist technical input and customer willingness to underwrite risk, so many engagements begin as small sponsored projects rather than full enterprise deployments.
Who they sell to
Most sell to technical or commercial sponsors inside other businesses: CTOs, heads of product, R&D directors, operations leads, finance buyers and, in regulated sectors, compliance or clinical decision-makers. Smaller customers may buy directly after a founder-led demonstration, while larger organisations usually need a technical sponsor, budget owner and procurement sign-off before a pilot expands. Sales cycles tend to be short when the buyer is testing a narrow workflow, but lengthen when information security, IP terms, data protection, clinical evidence or integration work is involved. Partner referrals, university networks and specialist advisers often matter alongside direct outbound.
What they buy
Most Cambridge startups tend to spend cautiously, but they still need the operating stack that lets a small team sell, ship and stay compliant. Common purchases include accounting, payroll, CRM, customer support, billing, contract management, security monitoring, cloud hosting, developer tooling, data storage, website infrastructure and project management software. More technical firms may also buy lab services, testing facilities, quality management systems, patent advice, grant-writing support and specialist recruitment. Buying is often founder-approved until a finance, operations or commercial lead is hired, so vendors need to make setup time, cash impact and immediate operational fit plain.
Why and how to sell to them
Startup buyers tend to evaluate suppliers when a trial customer becomes a contract, a grant creates delivery obligations, headcount rises, a senior commercial or finance hire arrives, or a regulated activity moves from planned to live. The main constraints are time, cash, proof and distraction: founders may like a tool but defer it if onboarding absorbs engineering or scientific capacity. Outbound works better when it links to a current trigger, such as first enterprise procurement, investor reporting, compliance evidence, repeatable sales activity or customer onboarding. Claims should be specific, short and tied to reducing operational drag rather than generic growth language.
How this list is built
Data sources
This list is built from UK Companies House filings, XBRL accounts data, and semantic analysis of each company's public website. Revenue and headcount figures come from the most recent filed accounts; where the company has not filed, values are estimated using a model trained on filed history and peer benchmarks and are labelled as estimates.
Classification
Rather than relying solely on SIC codes, Firmbase classifies each company semantically: the company's website is crawled, an AI model reads what the company actually sells, and the company is placed into the relevant industry and subsectors. SIC codes are used as one signal but not the only one. This means a company that registered under a generic SIC code but pivoted into (for example) fintech is correctly identified as fintech, not as its original SIC category.
Freshness
The underlying company data is refreshed from Companies House continuously; filings appear in the list within days of submission. The curated list ordering is regenerated when the underlying data moves meaningfully (company count changes by more than 5%, a new company enters the top-ranked segment, or the filed-revenue numbers for the top firms change). You can see the last-updated timestamp near the top of the page.
Also in Cambridge
Related directories
Frequently asked questions
How many startup companies are there in the Cambridge?↓
What counts as a startup company in this list?↓
Which are the largest startup companies in the Cambridge?↓
What do startup companies in the Cambridge actually do?↓
How does Cambridge startup compare internationally?↓
How is this list built and how fresh is the data?↓
How big are the typical startup companies in the Cambridge?↓
Are these mostly new or established startup companies?↓
What SIC codes does this use?↓
What buying signals should I look for?↓
Push these 69 companies into your pipeline.
Find the right decision-makers, see verified company data, and export your list in seconds.